These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24504973)

  • 1. Diagnostic assays for myeloperoxidase and myeloperoxidase deficiency.
    Nauseef WM
    Methods Mol Biol; 2014; 1124():537-46. PubMed ID: 24504973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic assays for myeloperoxidase deficiency.
    Nauseef WM
    Methods Mol Biol; 2007; 412():525-30. PubMed ID: 18453132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Released Myeloperoxidase Attenuates Neutrophil Migration and Accumulation in Inflamed Tissue.
    Rehring JF; Bui TM; Galán-Enríquez CS; Urbanczyk JM; Ren X; Wiesolek HL; Sullivan DP; Sumagin R
    Front Immunol; 2021; 12():654259. PubMed ID: 33959129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1. Role of the myeloperoxidase system.
    Klebanoff SJ; Coombs RW
    J Clin Invest; 1992 Jun; 89(6):2014-7. PubMed ID: 1318327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency.
    Nauseef WM; Root RK; Malech HL
    J Clin Invest; 1983 May; 71(5):1297-307. PubMed ID: 6189859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of myeloperoxidase in the microbicidal activity of polymorphonuclear leukocytes.
    Klebanoff SJ; Rosen H
    Ciba Found Symp; 1978 Jun 6-8; (65):263-84. PubMed ID: 225142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil dysfunction in the pathogenesis of cystic fibrosis.
    Wang G; Nauseef WM
    Blood; 2022 Apr; 139(17):2622-2631. PubMed ID: 35213685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestation of myeloperoxidase deficiency.
    Lanza F
    J Mol Med (Berl); 1998 Sep; 76(10):676-81. PubMed ID: 9766845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Harper L; Cockwell P; Adu D; Savage CO
    Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil Microparticles Deliver Active Myeloperoxidase to Injured Mucosa To Inhibit Epithelial Wound Healing.
    Slater TW; Finkielsztein A; Mascarenhas LA; Mehl LC; Butin-Israeli V; Sumagin R
    J Immunol; 2017 Apr; 198(7):2886-2897. PubMed ID: 28242649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of lysosomal enzymes by the respiratory burst of polymorphonuclear leukocytes. Possible involvement of myeloperoxidase-H2O2-halide system.
    Kobayashi M; Tanaka T; Usui T
    J Lab Clin Med; 1982 Dec; 100(6):896-907. PubMed ID: 6292313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification.
    Barone FC; Hillegass LM; Price WJ; White RF; Lee EV; Feuerstein GZ; Sarau HM; Clark RK; Griswold DE
    J Neurosci Res; 1991 Jul; 29(3):336-45. PubMed ID: 1656059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.
    Lehrer RI; Cline MJ
    J Clin Invest; 1969 Aug; 48(8):1478-88. PubMed ID: 5796360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes.
    Vogt W
    Immunobiology; 1996 Aug; 195(3):334-46. PubMed ID: 8877407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloperoxidase-deficient polymorphonuclear leucocytes. (I) Incidence in untreated myeloid leukaemia, lymphoid leukaemia and normal humans.
    Bendix-Hansen K; Kaspersen Nielsen H
    Scand J Haematol; 1983 May; 30(5):415-9. PubMed ID: 6304866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidation theory of non-steroidal anti-inflammatory drugs based upon the inhibition of luminol-enhanced chemiluminescence from the myeloperoxidase reaction.
    Pekoe G; Van Dyke K; Peden D; Mengoli H; English D
    Agents Actions; 1982 Jul; 12(3):371-6. PubMed ID: 6291348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon monoxide-releasing molecule 3 inhibits myeloperoxidase (MPO) and protects against MPO-induced vascular endothelial cell activation/dysfunction.
    Patterson EK; Fraser DD; Capretta A; Potter RF; Cepinskas G
    Free Radic Biol Med; 2014 May; 70():167-73. PubMed ID: 24583458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-mediated damage to human gingival epithelial cells.
    Altman LC; Baker C; Fleckman P; Luchtel D; Oda D
    J Periodontal Res; 1992 Jan; 27(1):70-9. PubMed ID: 1311041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase deficiency attenuates systemic and dietary iron-induced adverse effects.
    Xiao X; Saha P; Yeoh BS; Hipp JA; Singh V; Vijay-Kumar M
    J Nutr Biochem; 2018 Dec; 62():28-34. PubMed ID: 30218980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A real-time-based in vitro assessment of the oxidative antimicrobial mechanisms of the myeloperoxidase-hydrogen peroxide-halide system.
    Atosuo J; Suominen E
    Mol Immunol; 2019 Dec; 116():38-44. PubMed ID: 31593870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.